Media-OutReach Newswire AIM Vaccine has obtained clinical approval for two heavyweight products, creating new growth points for performance
Media-OutReach Newswire AIM Vaccine’s heavyweight single-product mRNA RSV Vaccine obtained the clinical trial approval
Media-OutReach Newswire Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers
Media-OutReach Newswire Fosun Participates in the 3rd BEYOND Expo to Deepen Biotechnology Innovation and Global Development
Media-OutReach Newswire Fosun Attends Forum Themed "Promoting Macao as a Platform Connecting China and Portuguese-speaking Countries" at the CIIE
Media-OutReach Newswire VinFuture Foundation launches science and technology webinar series "InnovaTalk 2022"